SEARCH RESULTS

Merci has found its future London location

Vimla Hunt - 26-mai-2015 11:03:08
Merci had already been announcing it since 2013 and its acquisition by the Gerbi family, that priority was to go to international development. Tokyo and New York may have been mentioned but it was London where the multibrands team were focused. Merci is thus getting ready to sign on for a location in the British capitals Kings Cross area. The surface area should be equivalent to the first Merci store opened in France in 2009 on Boulevard Beaumarchais, or approximately 16,000 square feet. The entire zone around the famous London train station is undergoing a major renovation and revamp, with several new offices and stores. Different buildings have been opening one by one since 2014, with the last ones scheduled to open in 2020. Merci has chosen not to comment on the London opening as yet.

Aryzta to acquire 49% stake in French food firm Picard

Myriam Kajji - 09-avr.-2015 17:04:12
Shares in Swiss-Irish food group Aryzta fell to their lowest level in 18 months after it announced plans to buy a stake in French food retailer Picard , surprising investors, who had thought the company was keen to exit the frozen foods sector. Aryzta said it had entered into exclusive negotiations to buy a 49 per cent stake in the French brand, which specialises in high-end frozen food, for €447 million from Lion Capital , a private- equity firm based in London. Under the terms of the deal, Aryzta would maintain an option to acquire 100 per cent stake in the business in three to five years. The acquisition, if it goes ahead, will be funded from the proceeds of its part sale of agribusiness group Origin and the disposal of its Tullamore-based Carroll Cusine, which look set to net Aryzta an estimated €444 million. News of the deal, however, sent shares in the Dublin and Zurich-listed company down. They fell 7.8 per cent or €4.75 to €58 in Dublin and by a similar margin in Zurich, their lowest close since September 2013. Nonetheless, chief executive Owen Killian insisted the investment in Picard was “consistent with Aryzta’s strategy of consumer relevancy through diversifying markets and channel positioning”. Picard has delivered consistent revenue, profit and market share growth over 40 years, he added. The French company sells mostly high-quality French produce through its 930 stores and commands 20 per cent of the country’s frozen food market. Recently, it has begun to expand internationally, opening stores in Belgium, Italy, Sweden and Japan. The deal would give Aryzta a direct retail presence on the ground for the first time. The company said it would treat the French group as an associate and that it expected the acquisition to make a net contribution of 3 per cent to underlying earnings per share (EPS), offsetting half of the negative 6 per cent impact of the Origin placement. Last week, it placed 49 million shares in Origin, some 60 per cent of its stake in the business, on the market, raising more than €404 million. The group will take two seats on the Picard board as part of the deal. “Other food companies have problems in frozen or are even selling these activities, so the market is a bit irritated by the move,” said Patrik Schwendimann, an analyst at Zuercher Kantonalbank. “The transaction in combination with the Origin sale will reduce earnings per share.” Vontobel analyst Jean-Philippe Bertschy said: “That move is surprising as Aryzta is expanding in a non- bakery sector and in a saturated market.”

IPSEN strengthens its position in botulinum toxin

Consumer Goods & Life Sciences Department - 02-sept.-2013 18:56:31
The third French pharmaceutical company, Ipsen, announced the acquisition of UK-based private life sciences company, Syntaxin, specialized in botulinum toxin engineering. The two companies first started collaborating in 2010. Under the terms of the agreement, Ipsen will pay €28 million upfront, as well as further contingent payments that could reach up to €130 million or more depending on the results. The transaction fits with Ipsen’s global strategy to strengthen its core technological platforms in peptides and toxins. Syntaxin has developed considerable experience in botulinum toxin biology, supported by an extensive portfolio of patents – with 75 patents granted and over 130 patents pending ( www.syntaxin.com ) Ipsen has also recently announced a sponsored research agreement with Harvard Medical School to discover novel engineered botulinum toxins for serious neurologic diseases. This successful French company has been operating in Ireland for more than 24 years. Source: www.ipsen.com  

PPR could launch a new label

Consumer Goods & Healthcare Department - 17-déc.-2012 18:29:03
Thanks to its disposal of assets, PPR (Pinault-Printemps-Redoute) plans to reinforce its luxury segment via acquisitions or by creation of a new label. “We have been talking about investing in a new luxury name. We no longer have brand names since Alexander McQueen and Stella McCartney have all reached the 100 million euros mark”, announced Chief Executive François-Henri Pinault in an interview. PPR has outlined its interest in medium-sized luxury brands to complete its portfolio, but it is the first time the group has suggested it might build a new Fashion house. Jewelry and menswear would be segments worth consideration.  When asked about the slowdown for luxury consumption on the Chinese market, Pinault declared that he is not worried about “ its potential for development over the long term”. Meanwhile, PPR unveiled its first acquisition in China with the jeweler Qeelin earlier this week. Source: FashionMag Magasine, 14th of December   

L’Oreal buys Cadum to extend domestic reach

Consumer Goods and Healthcare Department - 30-avr.-2012 12:25:36
L’Oreal, the worldwide French cosmetics leader, has recently bought the baby products company, Cadum for 200M€. With sales reaching 58M€ in 2011, Cadum represents a real opportunity for L’Oreal to access  more customers in its domestic market. "Cadum is an important acquisition for L’Oreal in France," the company’s consumer products chief, Herve Navellou, said in the statement. "It blends seamlessly into our strategy to conquer new consumers in France." L’Oreal, maker of Garnier shampoo, Lancôme creams and Yves Saint Laurent cosmetics, has virtually no debt and is looking to boost sales through bolt-on acquisitions. Souce : FashionMag 30/04/2012

Fareva continues to expand

Consumer Goods and Healthcare Department - 01-nov.-2011 11:17:33
The French company Fareva continues to expand through further acquisitions. After recently acquiring one of Pfizer facility in Richmond, USA, Fareva now turns to the Italian market and acquires Sigmar. Located near Milan, the Italian facility, which employs 112 people, manufactures OTC, food supplements and cosmetics.   Please not that Farmaclair, a subsidiary of Fareva will be attending the Biopharmaceutical Trade Event organised in the Résidence of France on the 8 th of November 2011

News in the French Life Sciences Industry

Consumer Goods and Healthcare Department - 24-oct.-2011 17:42:45
The pharmaceutical industry is consolidating more and more as groups create partnerships with one another to become more competitive in this tough environment. This is one of the reasons why Servier laboratory has been multiplying alliances these past few weeks. After the Galapagos and Hybrigenics ones, Servier had just signed a new union with the US biotech Miragen. This partnership focuses on the development of three products for the treatment of cardiovascular diseases thanks to therapies based on microARNs (the field of Miragen). According to the terms of the agreement, Servier will have the exclusive rights on the molecules developed by the US biotech all around the world except in the United States and Japan. As for the US group Abbott, it has decided to wipe off Fournier laboratories from the Dijon map. Indeed, the board has announced an employment zoning plan which will mainly affect the Fournier laboratories in Dijon and its 46 employees among which 24 will be made redundant, 2 will see their contacts modified into outsourcers and 20 will be transferred to other sites in Basel (Switzerland) and Paris. This reorganization will be effective before December, 31 st of 2011. The group became owner of Fournier in 2010 after the acquisition of Solvay In regards to the medical device industry, Snitem (French medtech industry association), has taken the decision to sign a framework agreement which is intended to better structure its co-operation with the government’s healthcare products economics committee (CEPS), which oversees the pricing of healthcare products in France. Snitem’s aim in the next few months is to analyse experiences in the different areas that are foreseen in the agreement: information exchange, post-market evaluation (“post-inscription”) studies… Such a review should enable Snitem to see how the framework agreement can offer a better structure in respect to industry’s relationship with the CEPS. (Source: Clinica)
About Us
Business France, the French Trade Commission in Dublin, is the trade section of the French Embassy in Ireland. Our bicultural team comprises 7 motivated professionals, dedicated to the promotion of the trade between Ireland and France, helping the Irish trade to source products from France and French exporters to find Irish partners. Our office is organised in business sectors: -     Agribusiness , -     Fashion, Housing, Healthcare , -     Infrastructure, Transport, Industry, -     ICT, Innovation, Services, Please click here to view our organigram. We organise Trade Events on a yearly planning, for which you may participate and register your interest. Furthermore, we are in a position to help you source products from France on an individual basis. If you are looking for French suppliers, please contact us or visit the French Exporters Directory ( www.ubifrance.com )   Busine

READ MORE

    
    You Buy France 

    

    Vivapolis  

   

    Healthindustry

   

    Axema

Facebook
Press area & Media Gallery